
The toxins normally bind very strongly to the antitoxins and are
thus not only inactive, but also prevent the production of more toxin
from the information encoded in the bacterial DNA. During the dormant
state, however, the antitoxins are degraded, and the toxins released
(step 1). The free toxins now bind to unoccupied antitoxins on DNA
within the area encoding the toxin-antitoxin couple (step 2). Binding
increasing amounts of toxin eventually leads to the release of the
molecules from the gene (steps 3 and 4) and finally to new toxin
production.
(Sep. 14, 2012) — A research group at Aarhus
University has gained unique insight into how bacteria control the
amount of toxin in their cells. The new findings can eventually lead to
the development of novel forms of treatment for bacterial infections.
Many pathogenic bacteria are able to go into a dormant state by
producing persister cells that are not susceptible to conventional
antibiotics. This causes serious problems in the treatment of
life-threatening diseases such as tuberculosis, where the presence of
persister cells often leads to a resurgence of infection following
medical treatment.
At the molecular level, the formation of persister cells is due to
the presence of toxins that are produced by the bacteria themselves, and
which enable them to enter the dormant state. During this hibernation
period, the bacteria constantly regulate the amount of toxin at exactly
the same level and thus maintain the dormant state.
In an article recently published in the American scientific journal
Structure, the researchers at the Department of Molecular Biology and
Genetics, Aarhus University, present new results that reveal the
molecular details of the regulatory mechanism of toxins.
By isolating and crystallising the toxin molecules and their
molecular companions -- the antitoxins -- and by subsequently exposing
the crystals to strong X-rays, the research team (consisting of the two
PhD students Andreas Bøggild and Nicholas Sofos and Associate Professor
Ditlev E. Brodersen) gained unique insight into how bacteria control the
amount of toxin in the cell.
The new findings can eventually lead to the development of entirely
new forms of treatment of bacterial infections that work initially by
blocking toxin function and production, and subsequently by using
traditional antibiotics to fight the pathogenic bacteria.
No comments:
Post a Comment